Search PubMed⌕ Search

Biomedical subjects

A D Mitchell

Publications and source records attributed to A D Mitchell.

At least 19 recordsLinked to original sources
PubMed1991

Influence of level of dietary protein or energy on effects of ractopamine in finishing swine.

The effect of ractopamine, a beta-adrenergic agonist, on growth, nutrient utilization, and carcass composition was studied in pigs fed either 18% CP, 12% CP, or 18% CP restricted (RES = 67% of ad libitum) diets. The 18 and 12% CP diets provided 3.52 and 3.68 Mcal of DE/kg, respectively. All pigs were fed a low-protein (12% CP) diet during pretreatment growth from 15 to 60 kg. Ractopamine at 20 or 30 ppm (30 ppm for RES pigs) in the diet was fed from 60 kg live BW until slaughter at 105 kg (9 pigs/treatment). No ractopamine treatment effect (P greater than .05) was observed for either daily gain or gain/feed, although gain/feed was improved by 8% in both of the ad libitum groups. Ractopamine treatment resulted (P less than .01) in an overall reduction of carcass lipid by 8%, an increase of carcass protein by 5%, and a 21% improvement in the efficiency of protein utilization; the greatest changes occurred in the pigs fed the 12% CP diet (-17%, +11%, and +32%, respectively). The ad libitum daily feed intake was 15% less for pigs fed the 12% CP diet than for those fed the 18% CP diet (P less than .01), and there was a 10% reduction in intake of both diets with the addition of ractopamine (P less than .05). Both carcass lipid and protein deposition seemed to be closely related to energy intake (P less than .01).(ABSTRACT TRUNCATED AT 250 WORDS)

Adipose Tissue↗
PubMed1991

Assessment of body composition of poultry by nuclear magnetic resonance imaging and spectroscopy.

Nuclear magnetic resonance (NMR) imaging and spectroscopy were used to assess body composition of the chicken and turkey poult. The NMR imaging was performed using a clinical, whole-body imaging system operating at 1.5 tesla (T; 63 MHz). Three-dimensional reconstruction of cross-sectional images made along the transaxial plane was used to estimate mass of the Pectoralis muscle of chickens ranging in weight from 140 to 2,760 g. Results indicate that NMR imaging can be used to determine size of the Pectoralis muscle (R2 = .99) in the bird, thus permitting repetitive measurements during the growth and development of the bird. The NMR spectroscopy was performed using an imaging spectrometer operating at 4.7 T (200 MHz). Integral areas of the water and lipid proton peaks of the spectra were compared with the water and lipid content of the whole body as determined by chemical analysis. Regression analysis of measurements made on turkey poults, ranging in weight from 115 to 630 g (n = 6), resulted in R2 values of .94 for NMR water proton peak area and total body water, .93 for NMR lipid proton peak area and total body lipid, and .96 for NMR water proton peak area and total body protein. From NMR spectroscopy of chickens weighing 528 +/- 18 g (n = 6), the relative area of the lipid peak correlated with whole-body lipid (R2 = .97). Thus, whole-body spectroscopy of smaller birds can be used to measure total body water, protein, and lipid content.

Animals↗
PubMed1990

Protein and energy relations in the broiler chicken. 8. Comparison involving protein- and lysine-adequate and inadequate diets on lipid metabolism.

Chickens were fed on diets containing either 12.8 MJ, 150 g crude protein (nitrogen x 6.25)/kg or 12.8 MJ, 200 g crude protein/kg to determine differences in metabolism. The diet containing 12.8 MJ, 150 g crude protein/kg contained either 8 or 12 g lysine/kg. Treatment variables examined in vitro were lipogenesis, glucose production and hepatic enzyme activities to compare metabolism in chicks fed on a low-protein, lysine-supplemented diet and a diet formulated to contain the required amount of lysine from intact protein. Growth was similar in chicks fed on diets containing either 12.8 MJ, 154 g crude protein with 12 g lysine/kg or 12.8 MJ, 200 g crude protein/kg. Net glucose production was greater (P less than 0.05) in liver explants from chickens fed on diets containing either 12.8 MJ, 154 g crude protein with 12 g lysine/kg or 12.8 MJ, 200 g crude protein/kg than in explants from chickens fed on 12.8 MJ, 150 g crude protein with 8 g lysine/kg. Pyruvate use for glucose production was greater (P less than 0.05) in chickens fed on a diet containing 12.8 MJ, 150 g crude protein with 8 g lysine/kg. The findings from the present study suggest that crystalline and 'natural' lysine additions to chick diets may influence metabolism differently.

Animals↗
PubMed1990

Response of low and high protein select lines of pigs to the feeding of the beta-adrenergic agonist ractopamine (phenethanolamine).

The effect of ractopamine, a phenethanolamine beta-adrenergic agonist, on growth, nutrient utilization and carcass composition was studied in two lines of pigs that were fed high (24%) or low (12%) protein diets. Of the two lines of pigs that had been selected for seven generations for rapid lean growth when fed either the higher (HS line) or low (LS line) protein diet, the HS line tended to exhibit a leaner carcass when fed either diet. Ractopamine, at 20 ppm in the diet, was fed from 60 kg live body weight until slaughter at 90 kg. When compared with their respective line-diet control group, the greatest response to ractopamine treatment was observed in the LS-12 group; at 90 kg, that group had 31% less carcass lipid (P less than .05) and 17% more carcass protein (P less than .05). Considering the change that took place only between 60 and 90 kg live body weight, this translated into 57% less lipid and 59% more protein deposited in the carcasses with ractopamine treatment. This group also was 73% more efficient (P less than .05) in converting dietary protein to carcass protein but 39% less efficient (P less than .05) in energy utilization. Response to ractopamine treatment was least by the LS-24 group, followed by the HS-12 and HS-24 groups. A line x diet x treatment interaction (P less than .05) was noted for whole-carcass lipid, backfat, longissimus muscle area and efficiency of protein utilization.(ABSTRACT TRUNCATED AT 250 WORDS)

Adipose Tissue↗
PubMed1990

Influence of dietary protein and recombinant porcine somatotropin administration in young pigs: growth, body composition and hormone status.

The influence of dietary protein and recombinant porcine somatotropin (rpST) administration on growth and body composition was investigated in barrows. Ten groups of six pigs starting at 30 kg were restrictively fed (approximately 80% of ad libitum) one of five diets containing 11, 15, 19, 23 or 27% protein. Diets contained skim milk (12%). Soybean meal diluted with cornstarch was used as the supplemental source of dietary protein. Diets were isocaloric (3.8 Mcal DE/kg) and all contained the same amount of lysine (18 to 20 g/kg). Thirty pigs were treated daily with rpST (100 micrograms/kg) by i.m. injection; the remaining pigs were treated with sterile diluent (control) for 42 d. Growth rate was greater in rpST-treated pigs at all levels of protein intake; however, the magnitude of the response to rpST treatment was lowest among pigs fed the diet containing 11% protein. Feed:gain ratio, backfat depth and carcass fat content were decreased in rpST-treated pigs compared to respective controls. Additionally, the concentration of carcass fat decreased concomitantly with an increase in dietary protein intake. Concentration of carcass protein increased linearly as dietary protein increased in control and rpST-treated pigs. In contrast, treatment with rpST was associated with an increased visceral mass; the concentration of protein and fat in the viscera was influenced by protein intake but not by rpST. These results, characterized by few treatment interactions, suggest that when energy intake is kept constant and appropriately fed pigs serve as controls, dietary protein and rpST influence growth and body composition by independent mechanisms.(ABSTRACT TRUNCATED AT 250 WORDS)

Adipose Tissue↗
PubMed1990

Selection line x diet interactions for two lines of pigs fed 12 or 24% protein diets.

An experiment with crossbred swine was conducted over six generations of selection based on an index (Index) of average daily gain in weight (ADG) in a test period from 56 d of age to 91 kg gross weight and average backfat thickness (ABF) measured from ultrasonic scans at 91 kg. Test pigs of the high protein select (HS) and control (HC) lines were fed a 24% crude protein (CP) diet and pigs of the low protein select (LS) and control (LC) lines were fed a 12% CP diet during the test period. The extent of genetic (selection line) x environmental (dietary) interaction effects was determined based on feeding closely related boars and gilts from both the HS and LS lines on both diets. Tests were conducted in 1986 and 1987 with progeny of the fifth and sixth generations of selection. Records for 472 pigs sired by 37 boars and out of 101 dams were analyzed for effects of selection and diets on AGE of pig at 91 kg, ADG, ABF, LMA (longissimus muscle area at the last rib) and Index. Statistically significant interactions effects of line x diet were noted (P less than .01) for AGE, ADG and Index, traits with low to moderate heritabilities (h2). For ABF and LMA, body composition traits with moderate or higher h2, interaction effects of line x diet were near zero. These results suggest that for best all-around future performance, traits such as AGE and ADG, selection probably should be practiced under dietary conditions under which future populations will be produced. For body composition traits such as ABF and LMA, selection probably would be more effective if pigs were fed a more enriched protein diet. However, as a practical matter, to more rapidly improve the genetic merit of the swine population, both the central station and on-the-farm testing programs should be conducted under standard commercial production systems.

Adipose Tissue↗
PubMed1989

Interrelationships between sex and exogenous growth hormone administration on performance, body composition and protein and fat accretion of growing pigs.

Forty-five pigs with an average initial live weight of 60 kg were used to investigate the effects of daily exogenous porcine pituitary growth hormone administration at two dose levels (pGH; 0, excipient buffer injected, and 100 micrograms.kg-1.d-1) for a 31-d period on the performance and body composition of boars, gilts and barrows allowed to consume feed ad libitum. Excipient boars consumed less feed, exhibited faster and more efficient growth (P less than .01) and produced less fat and more protein and water (P less than .01) in the empty body compared with excipient barrows, which in turn contained more fat and less water (P less than .05) in the empty body than did excipient gilts. These differences were largely eliminated by pGH administration, which induced differential effects in growth performance and body composition in boars, gilts and barrows. Growth hormone administration improved growth rate by 13, 22 and 16% and feed conversion efficiency by 19, 34 and 32% in boars, gilts and barrows, respectively. The reduction of body fat content (g/kg) elicited by pGH was 22, 36 and 33% for boars, gilts and barrows, respectively, with a corresponding increase (P less than .01) of body protein and water content. The magnitude of the pGH responses was greatest for gilts and barrows compared with boars, negating intrinsic sex-effect differences in growth performance and body composition of pigs. Pigs used in this study and treated with pGH exhibited a rate of protein deposition (approximately 225 g/d) far greater than previously reported, and as such redefine the genetic capacity for lean tissue growth by the pig.

Adipose Tissue↗
PubMed1989

Effects of exogenous porcine growth hormone administration between 30 and 60 kilograms on the subsequent and overall performance of pigs grown to 90 kilograms.

Twenty-eight barrows were used to investigate the effects of exogenous porcine growth hormone (pGH) administration (0 and 100 micrograms.kg-1.d-1) between 30 and 60 kg on the subsequent and overall performance and carcass composition of pigs grown to 90 kg. The pGH was administered by daily i.m. injection and all pigs were fed one diet. Control animals were pair-fed to the intake noted for pGH-treated pigs between 30 and 60 kg and all pigs were fed ad libitum from 60 to 90 kg. Pigs administered pGH had an improved rate (36%) and efficiency (28%) of gain and an improved protein accretion rate (46%) compared to excipient-treated pigs. Pigs previously treated with pGH continued to exhibit superior (P less than .01) rate and efficiency of gain, and the gain was associated with enhanced protein accretion during the quiescent (postinjection) period compared with excipient counterparts. Administration of pGH between 30 and 60 kg reduced carcass fat and increased carcass protein and water at 90 kg, although fat accretion rate was comparable to that of control pigs. Results indicate that, to varying degrees, the stimulatory effects of pGH on growth performance are sustained following cessation of hormone treatment.

Animals↗
PubMed1988

Evaluation of the L5178Y mouse lymphoma cell mutagenesis assay: methods used and chemicals evaluated.

A general protocol, modified from the one described by Clive and Spector (Mutat Res 31:17-29, 1975), was followed by two laboratories, Litton Bionetics, Inc., and SRI International, to evaluate 63 coded chemicals from 16 chemical classes for mutagenic activity at the thymidine kinase locus in L5178Y TK+/- 3.7.2C mouse lymphoma cells. The general protocol is discussed. Some procedural variations introduced by both laboratories are described and discussed in terms of their potential effect on the comparative results of the assay. Also included are the chemical structures, molecular weights, and functional classifications of the 63 chemicals. The assay appeared to tolerate the specific procedural variations in each laboratory without changing its reliability.

Animals↗
PubMed1988

Evaluation of the L5178Y mouse lymphoma cell mutagenesis assay: quality-control guidelines and response categories.

A data-based approach to formulating quality-control criteria for the mouse lymphoma cell forward mutation assay is described. Quality-control guidelines for solvent controls, positive controls, and compound-treated cultures were developed based on analysis of over 800 experiments. Frequency distributions of experimental parameters of control cultures, such as mutant frequencies, cloning efficiencies, and suspension growths, were examined. Cloning efficiency and relative total growth affected the variability only when the test chemical was highly toxic. This information was used to generate the quality-control criteria, which were applied to an experiment before it was evaluated for a response. The response categories for classifying the effect of test chemicals on the assay system are defined in terms of (1) the statistically significant differences in average mutant frequency between solvent control cultures and cultures exposed to a chemical and (2) the trend of the dose-related responses.

Animals↗
PubMed1988

Evaluation of the L5178Y mouse lymphoma cell mutagenesis assay: intralaboratory results for sixty-three coded chemicals tested at SRI International.

SRI used the L5178Y mouse lymphoma cell forward mutation assay to determine the mutagenic activity of 63 coded chemicals from 16 chemical classes. Replicate experiments were performed to assess the reproducibility of the assay within the laboratory. The evaluations (positive or negative) of the first two repeat experiments with the chemicals were the same for 116 (87%) of 134 tests. Evaluational differences between the first two experiments were fewer in the presence of induced S9 (6 tests) than in the absence of S9 (12 tests). The most commonly observed variability was the magnitude of positive mutagenic responses; this may be attributed to factors such as compound solubilities, S9 activation conditions, and differential recovery of mutant cells. Some consistency was observed in the responses of compounds of various chemical classes. Generally, antibiotics (ABO) and the azo dyes, azoxy and hydrazo compounds, diazoalkanes, nitriles and azides (AZO), were mutagenic with S9; alkyl, acyl, and aryl halides, halogenated ethers, and halohydrins (HAL) were more strongly mutagenic with than without S9; and monofunctional polycyclic aromatic hydrocarbons and fluorenones (PAH) were mutagenic only with S9. Amine-1-oxides (AMO), alkyl and aryl epoxides (EPO), and nitroalkanes, nitroaromatics, nitroquinolines, nitrofurans, and nitroimidazoles (NIT) were mutagenic with and without S9; amides, sulfonamides, aromatic amines, aliphatic amines, hydroxylamines, and benzidine and its derivatives (AMI) were mutagenic without S9; and methyl carbamate (the only monofunctional carbamate) and thioureas (CBM) induced a negative response under both conditions.

Animals↗
PubMed1988

Evaluation of the L5178Y mouse lymphoma cell mutagenesis assay: interlaboratory reproducibility and assessment.

The L5178Y mouse lymphoma cell mutagenesis assay is used to detect the mutagenic activity of chemicals in a mammalian cell system. To evaluate this assay we compared the results of assays performed independently on 63 chemicals by laboratories at SRI International and Litton Bionetics, Inc. The two laboratories used similar protocols. The solvent and positive control mutant frequencies and cloning efficiencies obtained by the two laboratories were similar, which justified the use of the same quality-control criteria and analytical procedures for analyzing the results from both laboratories. The rate of concordance between the two laboratories was 92% for tests in the absence of S9 activation and 95% for tests in its presence. The results of the assays agreed for 57 of the 63 chemicals; three chemicals could not be compared because there were questionable calls in at least one of the laboratories; the results disagreed for the three remaining chemicals. The concordance rate for these overall assay evaluations was 95%. The interlaboratory concordance rates were similar to concordance rates for replicate experiments within the laboratories (96% at LBI, 94% at SRI). The mouse lymphoma cell mutagenicity results are concordant with the rodent chronic assay results in 78% of 50 chemicals and with the Salmonella assay results in 79% of 56 chemicals. Fifteen carcinogens were examined for genotoxic effects in mouse lymphoma, Salmonella, Chinese hamster ovary (CHO) chromosomal aberration, and CHO sister chromatid exchange assay. Eight of these were positive in all four assays. Of the seven noncarcinogens that were tested in these four assays, none was negative in all four. The main conclusion to be drawn from this study is that the mouse lymphoma cell forward mutation assay, as performed and evaluated in this study, detects chemical mutagenicity in a manner that is highly consistent with other genetic endpoints as well as rodent carcinogenicity studies. Thus the assay quality control and response criteria established in this study led not only to a high degree of reproducibility but also to an apparently reliable detection of mutagenic activity.

Animals↗
PubMed1988

The mutagenic activity of selected compounds at the TK locus: rodent vs. human cells.

The mutagenic (TFT resistance) and toxic responses of mouse lymphoma (MOLY) L5178Y cells and human lymphoblast (HULY) TK6 cells were compared for 13 chemicals. The mutagenic activities of 8 of the 13 chemicals (62%) examined in the HULY and MOLY assays are in agreement - the results being judged positive in both assays. However, a dramatic difference is observed when the two conditions of metabolic activation are considered separately; the overall concordance of 8/13 has been achieved by combining a 13/13 (100%) agreement in the absence of S9 with a 1/6 (17%) agreement in the presence of S9. In the absence of S9, the concentration ranges, lowest significant doses, and shapes of the concentration-response curves for both toxicity and mutagenicity were similar in spite of the differences in exposure times (4 h for MOLY, 20 for HULY) and expression times (2 days for MOLY, 3 days for HULY). The general agreement observed in the absence of S9 contrasted with the differences manifested in its presence. 6 compounds which were negative in the absence of S9 were tested in both the MOLY and HULY assays in the presence of S9. Of the 6 chemicals, only 1 was positive in both MOLY and HULY under the latter condition; 4 others were positive in MOLY and negative in HULY whereas 1 was positive in HULY and negative in MOLY.

Animals↗
PubMed1988

Chicken hepatic metabolism in vitro. Protein and energy relations in the broiler chicken--VI. Effect of dietary protein and energy restrictions on in vitro carbohydrate and lipid metabolism and metabolic hormone profiles.

1. Ross male broiler chicks growing from 14 to 28 days of age were fed 14 and 20% protein diets (4 kcal day-1/body wt0.66) or 20 and 28% protein diets (2.8 kcal day-1/body wt0.66) in a 2 x 2 factorial arrangement to determine the effects of protein and energy intakes on in vitro lipogenesis (IVL) and net glucose production (NGP). Plasma concentrations of insulin, glucagon, thyroid hormones (T3 and T4) and somatomedin-C (Sm-C) were estimated by radioimmunoassay. 2. There was a significant (P less than 0.05) decrease in IVL in the chicks given the higher daily protein intake. 3. The higher protein intake increased (P less than 0.05) NGP while the lower energy intake decreased (P less than 0.05) NGP. 4. Insulin, both thyroid hormones and Sm-C were affected by dietary energy and protein intakes.

Animals↗
PubMed1988

Survey of the long term incidence of osteonecrosis of the hip and adverse medical events in rheumatoid arthritis after high dose intravenous methylprednisolone.

A prospective, randomised, double blind, matched cohort survey using retrospective data was undertaken to assess the long term incidence of osteonecrosis of the hip and adverse medical effects occurring after intravenous pulsed methylprednisolone used in the treatment of rheumatoid arthritis over the period 1977-86. One hundred and forty three patients were matched for age, sex, duration and severity of the disease, erosive and serological status. Information was obtained by direct questioning and from hip x rays, the latter being read independently by two 'blind' radiologists. Two definite cases of osteonecrosis were identified, one in both the treated and control groups and three possible cases (radiological disagreement) in the treated group. Adverse medical events, when analysed by systems, were similar in both groups. This study did not provide evidence of increased osteonecrosis of the hip or adverse medical events in the treated group compared with the control group.

Adult↗
PubMed1988

Interrelationships between energy intake and endogenous porcine growth hormone administration on the performance, body composition and protein and energy metabolism of growing pigs weighing 25 to 55 kilograms live weight.

Thirty-six barrows were used in a 2 X 3 factorial experiment to investigate the effects of porcine growth hormone (pGH) administration (USDA-pGH-B1; 0 and 100 micrograms.kg body weight-1.d-1) and three levels of feeding of a single diet (EI; ad libitum, 1.64 and 1.38 kg/d) on the performance, body composition and rates of protein and fat deposition of pigs growing over the live weight phase 25 to 55 kg. Raising EI resulted in linear increases in growth rate and in protein and fat accretion but had no effect on the feed to gain ratio (F/G). Carcass fat content and carcass fat measurements also increased with EI, whereas carcass protein and water decreased (P less than .01). Growth hormone administration resulted in improvements in growth rate (16 to 26%), F/G (23%), protein deposition (34 to 50%) and increases in carcass protein and water at each level of feeding, but reduced ad libitum feed intake (P less than .01), carcass fat content (P less than .01) and carcass fat measurements (P less than .01). Estimated maintenance energy expenditure was increased by pGH administration (2.02 vs 1.72 Mcal digestible energy/d). Results indicate that the effects of pGH on growth performance and energy and protein metabolism were largely independent of, and additive to, the effects of energy intake.

Animals↗